Article Text

Download PDFPDF
Adding 8 weeks of behavioural therapy to atomoxetine does not improve classroom behaviour in children with ADHD

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.



Is the combination of atomoxetine and behavioural therapy (BT) more effective than drug treatment alone for children with attention-deficit hyperactivity disorder (ADHD)?


56 children (45 boys) aged 6–12 years with DSM-IV-TR ADHD of moderate severity (mean Clinical Global Impressions–Severity of Illness Score 4.3). Exclusions: history of seizures, contraindication to atomoxetine, previous documented failure of atomoxetine treatment (at least 0.8 mg/kg/day for at least 3 weeks), other serious psychopathology, IQ less than 75 and no history of ADHD-related impairment at school. Prior ADHD medication use was allowed: 37% had never used stimulants and 12.5% had previously used atomoxetine.


Community setting, Buffalo, New York, USA; March 2007 to May 2008.


Atomoxetine plus BT or atomoxetine alone for 8 weeks. BT involved an 8-week parenting course, comprising weekly sessions of the Community Orientated Parent Education (COPE) programme; a child social skills course (eight 2 h sessions running simultaneously to COPE) covering skills of cooperation, participation, validation and communication; and a teacher-implemented daily report card of classroom behaviour. Atomoxetine was dosed openly (mean dose 1.44 mg/kg/day). …

View Full Text


  • Sources of funding Eli Lilly and Company, Indianapolis, Indiana, USA.


  • Competing interests None.